Who is sponsoring NCT04485520?

NCT04485520 is sponsored by Julieta María Méndez Romero.

What drugs are being tested in NCT04485520?

Interventions in NCT04485520: CARICA PAPAYA MOUTHWASH, CHLORHEXIDINE MOUTHWASH.

What condition does NCT04485520 study?

NCT04485520 studies Streptococcus, Other Specified Group, Dental Plaque.

Is NCT04485520 still recruiting?

NCT04485520 is currently completed. Last updated 18 August 2021.

Last reviewed 2021-08-18 · How we verify

NCT04485520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans

Completed NA Last updated 18 August 2021

What this trial tests

NA trial testing CARICA PAPAYA MOUTHWASH in Streptococcus, Other Specified Group in 40 participants. Completed in 21 October 2017.

Timeline

21 September 2017

Primary endpoint
21 October 2017

21 October 2017

Quick facts

Lead sponsor	Julieta María Méndez Romero
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	40
Start date	21 September 2017
Primary completion	21 October 2017
Estimated completion	21 October 2017
Sites	1 location across Paraguay

Drugs / interventions tested

CARICA PAPAYA MOUTHWASH
CHLORHEXIDINE MOUTHWASH — full drug profile →

Conditions studied

Streptococcus, Other Specified Group — all drugs for Streptococcus, Other Specified Group →
Dental Plaque — all drugs for Dental Plaque →

Sponsor

Julieta María Méndez Romero

Who can join

18 and older, any sex, with Streptococcus, Other Specified Group or Dental Plaque. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Papaya has effects on oral pathogenic microorganisms, it also has anticoagulant quality, amebicidal action, antimicrobial, bacteriostatic and antifungal activity on different bacteria, especially on Streptococcus mutans, this can be exploited in the dental area. The objective of the study was to determine the efficacy of Carica Papaya peel extract (suckling) as an inhibitor of Streptococcus Mutans in students of the dental faculty of the National University of Caaguazú in 2018.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Julieta María Méndez Romero trials

Trials by the same sponsor.

NCT04410666 — Antibacterial Effect of the Infusion of Green Tea Used as a Mouthwash on Saliva and Bacterial Plaque · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04485520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Julieta María Méndez Romero
Last refreshed: 18 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04485520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing